Table 2 (A) Clinical presentation and nodal sites on initial presentation (N = 100); (B) organomegaly and extra-nodal sites on initial presentation (N = 100)
From: The clinico-pathological profile of non-Hodgkin’s lymphoma in Aseer region of Saudi Arabia
(A) Patient profile | N (%) | (B) Patient profile | N (%) |
|---|---|---|---|
Constitutional symptoms | Organomegaly (not LNs) | ||
Positive (+ve) | 52 (52) | Liver | 23 (23) |
Negative (−ve) | 45 (45) | Spleen | 30 (30) |
Unknown | 3 (3) | Pancreas | 1 (1) |
Stage of NHL | 0 (0) | Cecum | 1 (1) |
I | 1 (1) | Parotid | 2 (2) |
I (E) | 0 (0) | Thyroid | 2 (2) |
I (S) | 2 (2) | Kidney | 1 (1) |
II | 4 (4) | Ovary | 1 (1) |
II (E) | 0 (0) | Stomach | 1 (1) |
II (S) | 3 (3) | Colon | 0 (0) |
III | 2 (2) | Duodenum | 1 (1) |
III (E) | 1 (1) | Brain | 1 (1) |
III (S) | 3 (3) | ||
III (SE) | 25 (25) | Presentation with extranodal (primary site other than LNs) | |
IV | 59 (59) | Liver | 2 (2) |
Unknown | Spleen | 0 (0) | |
Site of lymphadenopathy | Pancreas | 0 (0) | |
Axillary | 3 (3) | Cecum | 3 (3) |
Supraclavicular | 3 (3) | Parotid | 1 (1) |
Cervical | 6 (6) | Thyroid | 5 (5) |
Mesenteric LNs | 6 (6) | Kidney | 2 (2) |
Paravertebral | 1 (1) | Ovary | 1 (1) |
Epigastric LNs | 1 (1) | Stomach | 13 (13) |
Nasopharyngeal | 2 (2) | Colon | 2 (2) |
Submandibular | 3 (3) | Duodenum | 1 (1) |
Generalized | 43 (43) | Brain | 0 (0) |
Retroperitoneal | 1 (1) | Small bowel | 3 (3) |
Pre-tracheal | 1 (1) | Tongue | 2 (2) |
Unknown | 21 (21) | Cheek deep tissue | 2 (2) |
Bone marrow (BM) | 5 (5) | ||
Eyes | 0 (0) | ||
Max. size of lymphadenopathy | Skin | 1 (1) | |
< 2 cm | 12 (12) | Breast | 2 (2) |
2–4 cm | 6 (6) | Bones | 2 (2) |
> 4 cm | 31 (31) | Jejunum | 1 (1) |
Unknown | 51 (51) | Soft tissue | 1 (1) |